It’s no secret that COVID-19 has severely stressed the healthcare system both in the US and abroad. America has been enacting new policies and applying short-term solutions during this time in order to get through the pandemic. Will we treat this as a one-off or effect lasting change in the healthcare industry?
This week on Nextopic: As the world navigates the COVD-19 pandemic, RA Capital Managing Partner Peter Kolchinsky dissects the shortcomings of the US healthcare system which have become a point of heated debate. A biotechnology investor by trade and a Ph.D. in Virology, Peter walks us through the world of biotechnology entrepreneurship and investment, sheds a light on some lesser-known pandemics, and reviews the state of the pharmaceutical and insurance industries. He further discusses the economic incentives (or lack thereof) that influence the ability of individuals to receive proper healthcare. “The reality is America’s doing the best job in the world of funding innovation and it’s doing a pretty bad job in making that innovation affordable to all of its own citizens,” he says.
Peter explores new and innovative ideas on how to incentivize biotechnology research and modify healthcare policy to better serve us all through the nation-wide adoption of a universal healthcare system.
Listen now and subscribe so you don’t miss out.